Covered recipient · General Payments record
LUKE BARRE
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$5,015.45
- Reported across 241 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $596.32 | 29 |
| Education | $79.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $219.11 | 13 |
| Amgen Inc. | $202.41 | 10 |
| Janssen Biotech, Inc. | $79.99 | 1 |
| GENZYME CORPORATION | $72.53 | 2 |
| E.R. Squibb & Sons, L.L.C. | $28.14 | 1 |
| Acerta Pharma LLC | $26.84 | 1 |
| GlaxoSmithKline, LLC. | $24.72 | 1 |
| UCB, Inc. | $22.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.54 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103283317 | CMS |
| ABBVIE INC. | $4.93 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103283319 | CMS |
| ABBVIE INC. | $18.27 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103283321 | CMS |
| ABBVIE INC. | $21.28 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103283323 | CMS |
| ABBVIE INC. | $25.68 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103283325 | CMS |
| ABBVIE INC. | $8.53 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103283327 | CMS |
| ABBVIE INC. | $4.59 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103283329 | CMS |
| ABBVIE INC. | $21.36 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103283331 | CMS |
| ABBVIE INC. | $28.21 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103283333 | CMS |
| ABBVIE INC. | $17.62 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103283335 | CMS |
| ABBVIE INC. | $24.33 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103283337 | CMS |
| ABBVIE INC. | $17.89 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103283339 | CMS |
| ABBVIE INC. | $3.88 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103283341 | CMS |
| Amgen Inc. | $17.05 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111525144 | CMS |
| Amgen Inc. | $22.15 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111525146 | CMS |
| Amgen Inc. | $15.66 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117198266 | CMS |
| Amgen Inc. | $25.82 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117198268 | CMS |
| Amgen Inc. | $11.86 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111525142 | CMS |
| Amgen Inc. | $22.82 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117198270 | CMS |
| Amgen Inc. | $22.59 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111525148 | CMS |
| Amgen Inc. | $27.16 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111525154 | CMS |
| Amgen Inc. | $19.40 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111525150 | CMS |
| Amgen Inc. | $17.90 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111525152 | CMS |
| AstraZeneca Pharmaceuticals LP | $26.84 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104245801 | CMS |
| E.R. Squibb & Sons, L.L.C. | $28.14 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101442223 | CMS |
| GENZYME CORPORATION | $32.16 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139863930 | CMS |
| GENZYME CORPORATION | $40.37 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139863976 | CMS |
| GlaxoSmithKline, LLC. | $24.72 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116500101 | CMS |
| Janssen Biotech, Inc. | $79.99 | 04/30/2024 | Education | Undisputed | 01/23/2026 | 1078693499 | CMS |
| UCB, Inc. | $22.57 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143065207 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.